Accelrys, Inc. (NASDAQ:ACCL)
| CAPS Rating |
|
|---|---|
| Open | $7.40 |
| Previous Close | $7.49 |
| Daily Range | $7.23 - $7.46 |
| 52-Week Range | $5.68 - $8.90 |
| Market Cap | $406.76M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 42,002 |
| Average Daily Volume | 0 |
ACCL
VS S&P 500 (SPY)
How do you think ACCL will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ACCL Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ACCL News and Commentary
- Find a Hidden Opportunity in Faster Data – The Motley Fool
- Is Ebix a Buffett Stock? – The Motley Fool
- Simulations Plus: Flying Under the Radar – SeekingAlpha
- 5 Deathbed Stocks? – The Motley Fool
- Accelrys Crawls Forward: Fool by Numbers – The Motley Fool
- No Acceleration at Accelrys: Fool by Numbers – The Motley Fool
- Is Microsoft on Drugs? – The Motley Fool
- Accelrys Accelerates Help for the Life Sciences – The Motley Fool
- More Big 2005 Nanotech News – The Motley Fool
- The Next Big Little Market – The Motley Fool
- A New Nanotech Fund – The Motley Fool
- Nanotech's Promise Hits the Pedal – The Motley Fool
- What Drives Accelrys? – The Motley Fool
- The Players and Pretenders of Nanotech – The Motley Fool
Related News and Articles
- Illuminating the Way Forward for Genomics – The Motley Fool
- Life Technologies' Sequence of Success – The Motley Fool
- Has Sequenom Become the Perfect Stock? – The Motley Fool
- Hang Tight: This Bid Will Increase – The Motley Fool
RSS Headlines
Fool UK
